Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.
Vanessa L MerkerAndrés J LessingIrene MossMaureen HusseyBeverly OberlanderTraceann RoseRaquel ThalheimerTracy WirtanenPamela L WoltersAndrea M GrossScott R Plotkinnull nullPublished in: Neurology (2021)
Involving patient representatives in REiNS improved perceived quality of neurofibromatosis clinical trial outcome measures. Negotiating sufficient opportunities to engage, fostering an inclusive atmosphere, and navigating time pressures are key to effective patient engagement.